Intas Pharma Limited

Intas derives its competitive edge from successful and strategic moves it has made in the areas of manufacturing R & D biotechnology and global operations. The current decade has witnessed Intas fortifying its presence in the segments of CNS Cardiovascular Diabetology Gastroenterology Urology and Pain management It has ventured successfully into high-growth areas of Animal Health Care Oncology and Biotechnology to augment its base Its state-of-the-art manufacturing facility for Cytotoxic products is one of its kind in the entire Asia-Pacific region Through strategic investment in the manufacturing facility at Matoda (District: Moraiya) Gujarat Intas has upgraded its manufacturing capabilities. It has the regulatory approval of agencies like FDA MHRA TGA ANVISA and MCC A modern manufacturing facility set up at Dehradun(Uttarakhand North India) has further synergised the manufacturing capabilities to meet the increasing demand Intas has its presence in 42 countries worldwide and has made successful forays into contract manufacturing and contract marketing tie-ups across the world